
Surgery Partners (SGRY) Stock Forecast & Price Target
Surgery Partners (SGRY) Analyst Ratings
Bulls say
Surgery Partners is executing specific strategies to accelerate SS growth, with a focus on supporting and expanding services in surgical facilities in its existing markets. They are also investing in technology and recruiting for high-acuity specialties, positioning themselves as a more attractive and efficient alternative to traditional hospitals. Furthermore, divestiture of non-core assets and efficiency measures should improve cash conversion and increase margins, making Surgery Partners a strong value proposition for the US healthcare system.
Bears say
Surgery Partners is currently facing headwinds due to the impact of the COVID-19 pandemic on its business operations, with softer consolidated case volumes and higher staffing costs leading to margin pressure. Its recent divestiture of the Idaho Falls market is a positive step in its portfolio optimization strategy, but the company still faces challenges in meeting its previous targets for revenue and acquisitions. Additionally, the sustainability of the recent rebound in demand and patient volumes is uncertain, and the company will likely continue to face regulatory and reimbursement challenges.
This aggregate rating is based on analysts' research of Surgery Partners and is not a guaranteed prediction by Public.com or investment advice.
Surgery Partners (SGRY) Analyst Forecast & Price Prediction
Start investing in Surgery Partners (SGRY)
Order type
Buy in
Order amount
Est. shares
0 shares